evenfolio

IT · NSE: PERSISTENT

Persistent Systems

Price as of 12 Nov 2026
6,030.00+0.95%

Q2 FY27 earnings call · Guided by management

Call held 15 Oct 2026 · Read the filing on NSEFiling

16–17​%EBIT marginKalra · Q&A · p. 19
1.25​USD billionLong-term financing for NagarroKalra · p. 7
50​USD millionNagarro one-time transaction expenses · three to four quartersKalra · p. 7
25–30​USD millionFurther Nagarro transaction costs · next two quartersTeredesai · p. 9
M.Cap
₹95,123Cr
P/E
52.8×
1Y return
−1.70%
From 52W high
−8.6%

Highlights are read by AI from the company's filing and can contain mistakes. Check the source page linked to each line.

Share price

Results Q2 FY27, as filed · consolidated · ₹ Cr

Q2 FY27Q2 FY26YoYQ1 FY27QoQ
Revenue4,6643,581+30.3%4,303+8.4%
EBITDA633683-7.3%697-9.1%
EBITDA margin13.6%19.1%-550 bps16.2%-261 bps
PBTProfit before tax454617-26.4%623-27.2%
Net profit352471-25.4%483-27.2%
EPS (₹)22.2230.15-26.3%30.51-27.2%

From the company's own results filing on NSE. Net profit is the owners' share. Growth and the dotted lines are worked out from the filed figures. In Q1 FY27 the filing tags the owners' profit as ₹0 Cr against its own period profit; the period profit less minority interest is shown.

Guidance

Margin · long term16-17%Margin aspiration of 16 to 17%, stated as not guidance

More figures from the call

Company · Debt and working capital
5–6​%Cost of acquisition debt
“it is pretty much in the range of doing 5 to 6%, but it will all depend upon the day we actually do the transaction. So, you can right now assume between 5 to 6% on a net basis.”
Vinit Teredesai · Executive Director and Chief Financial Officer · Q&Ap. 22

In short

  1. 01Q2 FY27 revenue was USD 487.6 million, up 7.8% quarter-on-quarter and 20% year-on-year.
  2. 02EBIT margin was 15%; management's stated aspiration is 16 to 17%, and it says this is not guidance.
  3. 03Nagarro deal: about 94.04% of shares secured; closure expected by Q4-CY26 or Q1-CY27.
  4. 04USD 1.25 billion to be raised in debt and equity, of which USD 450 million through equity; debt cost assumed at 5 to 6%.
  5. 05Nagarro one-time expenses expected at about $50 million over three to four quarters; reported PAT hit by about 3.1% in Q2.
  6. 06Q2 TCV was USD 633.5 million; some deals slipped and decision making slowed in recent weeks.
  7. 07Management says healthcare should start seeing growth and Europe's decline came from two client-specific events.

Order book

Q2 TCV USD 633.5 million; new bookings TCV USD 367.1 million

Sandeep Kalra · Executive Director and Chief Executive Officer · p. 4
“Coming to the order book for the quarter, the total contract value for the quarter stood at USD 633.5 million, with total contract value of new bookings coming in at USD 367.1 million.”

Q2 ACV USD 481 million; new bookings ACV USD 262.3 million

Sandeep Kalra · Executive Director and Chief Executive Officer · p. 4
“The annual contract value of bookings for this quarter was USD 481 million, out of which the annual contract value from new bookings contributed to USD 262.3 million.”

Software, High-Tech and Emerging Industries: Last quarter's large deal: 6.5 years, over $650 million, with a top tech company

Nitish Shrivastava · Chief Technology Officer · p. 12
“A strong validation of Software Reinvention Services is the large deal we signed last quarter, a 6.5-year engagement worth more than $650 million with one of the largest technology companies spanning product development support and cloud operations across multiple SaaS products.”

Software, High-Tech and Emerging Industries: Hyperscaler picked Persistent as preferred partner for forward-deployed engineering

Saurabh Dwivedi · Corporate Vice President · p. 13
“A leading hyperscaler has selected Persistent as a preferred partner for its newly formed forward-deployed engineering organization to scale legacy modernization and transformation programs.”

Banking, Financial Services and Insurance: Fortune 500 US insurer picked Persistent for AI-led modernization

Saurabh Dwivedi · Corporate Vice President · p. 13
“A Fortune 500 US insurer has selected Persistent as its AI-led modernization partner for its personal lines policy administration.”

Segments

Europe: Europe revenue fell 8.5% YoY due to two client-specific events

Sandeep Kalra · Executive Director and Chief Executive Officer · p. 5
“Revenue in Europe declined 8.5% largely because of two client-specific events.”

Europe: Europe decline called one-off, not a sign of wider regional demand

Sandeep Kalra · Executive Director and Chief Executive Officer · p. 5
“Both are one-off, client-specific events rather than a sign of broader geographic demand trends.”

North America: North America revenue grew 22.5% YoY

Sandeep Kalra · Executive Director and Chief Executive Officer · p. 5
“North America revenue grew by 22.5%.”

India; rest of the world: India revenue grew 19.4% and rest of world 67% YoY

Sandeep Kalra · Executive Director and Chief Executive Officer · p. 5
“Revenue in India grew by 19.4% and the rest of the world grew by 67% although on a smaller base.”

Software, High-Tech and Emerging; BFSI; Healthcare and Lifesciences: YoY growth: Hi-Tech 28.5%, BFSI 16.2%, Healthcare and Lifesciences 12%

Sandeep Kalra · Executive Director and Chief Executive Officer · p. 5
“This quarter's growth was led by Software, High-Tech and Emerging verticals coming in at 28.5% followed by Banking, Financial Services and Insurance at 16.2% and Healthcare and Lifesciences vertical at 12% respectively on a year-on-year basis.”

Demand

Top 5 client revenue up 38.9%, top 100 up 21.6% YoY

Sandeep Kalra · Executive Director and Chief Executive Officer · p. 5
“Our top 5 customers' revenue grew by 38.9%, top 10 by 29.9%, top 20 by 25%, top 50 by 24% and top 100 by 21.6%.”

Pipeline healthy; all segments expected to grow; no forward guidance given

Sandeep Kalra · Executive Director and Chief Executive Officer · Q&A · p. 15
“Now in terms of the outlook our pipeline is healthy, we don't give forward looking guidance but we are relatively confident that all the segments will kind of grow very well.”

BFSI; Healthcare Life Sciences: BFSI and Healthcare slower in AI adoption than high-tech

Sandeep Kalra · Executive Director and Chief Executive Officer · Q&A · p. 15
“And since we work with them, we are very comfortable taking the same to the BFSI and Healthcare Life Sciences verticals, which are a little slower in adoption”

Healthy pipeline at the consolidating customer; hope to grow it much bigger

Sandeep Kalra · Executive Director and Chief Executive Officer · Q&A · p. 25
“we are seeing a very healthy pipeline and we are relatively hopeful of growing that customer much bigger.”

USD 10 million+ clients rose from 25 to 34 YoY

Sandeep Kalra · Executive Director and Chief Executive Officer · p. 5
“Those in USD 10 million plus category increased from 25 to 34.”

Margins and costs

Q2 EBIT Rs 6,977.2 million, up 19.5% YoY; EBIT margin 15%, down 130 bps YoY

Vinit Teredesai · Executive Director and Chief Financial Officer · p. 8
“EBIT for this quarter was Rs.6,977.2 million, translating to a growth of 19.5% year-on-year. EBIT margins for Q2 FY27 came in at 15%, 130 basis points declined year-on-year.”

Wage hike cut margin by 180 bps; net 140 bps after lower ESOP costs

Vinit Teredesai · Executive Director and Chief Financial Officer · p. 8
“As you would remember, this is the quarter when we have the yearly wage hike coming into effect. This impacted our margins by 180 basis points. However, lower ESOP costs enabled us to absorb part of this impact, leaving us with a net impact of 140 basis points.”

Lower utilisation cut EBIT margin by 20 bps

Vinit Teredesai · Executive Director and Chief Financial Officer · p. 8
“Lower utilization led to a 20 basis impact on our EBIT margins.”

Large deal licences raised amortisation by about USD 4 million, a 90 bps margin hit

Vinit Teredesai · Executive Director and Chief Financial Officer · p. 8
“This investment in the third-party tools and licenses led to an increase in the quarterly amortization of approximately USD 4 million, which had an impact of 90 basis points on our Q2 EBIT margin.”

Large deal margin impact expected to reduce as spend is optimised and revenue scales

Vinit Teredesai · Executive Director and Chief Financial Officer · p. 8
“As we optimize the spend and our revenue scales in future, the impact on our margins will gradually reduce.”

Debt and working capital

Higher finance charges from higher receivables financing

Vinit Teredesai · Executive Director and Chief Financial Officer · p. 9
“During the quarter, we had higher finance charges on account of higher receivables financing.”

Record collections improved cash despite dividend and Nagarro expenses

Vinit Teredesai · Executive Director and Chief Financial Officer · p. 9
“We are happy to report that we had record collections during the quarter which helped to improve the cash position in spite of payment of final dividend and exceptional expenses related to Nagarro transactions.”

Cash and investments Rs 29,996.7 million vs Rs 27,044 million last quarter

Vinit Teredesai · Executive Director and Chief Financial Officer · p. 9
“Total cash and investments stood at Rs. 29,996.7 million, around $315 million as of September 30, 2026 as against Rs. 27,044 million at the end of the previous quarter.”

Billed DSO fell to 50 days from 61 days

Vinit Teredesai · Executive Director and Chief Financial Officer · p. 9
“The billed DSO decreased to 50 days as against 61 days in the previous quarter,”

TTM OCF to PAT 96.6% vs 76.2% last quarter

Vinit Teredesai · Executive Director and Chief Financial Officer · p. 10
“OCF to PAT improved to 96.6% in Q2 FY27 compared to 76.2% in the previous quarter.”

Fund raising

Euro 1.4 billion 18-month bridge loan to be replaced with longer-tenure funding

Sandeep Kalra · Executive Director and Chief Executive Officer · p. 7
“In terms of financing, we intend replacing the Euro 1.4 billion 18-month bridge loan with longer tenure, capital and favorable terms.”

Shareholders approved the funding mix at the October 5 EGM

Sandeep Kalra · Executive Director and Chief Executive Officer · p. 7
“We have received the shareholder approval for the above funding mix at the Extraordinary General Meeting held on October 5th.”

Acquisitions and new business

About 94.04% of Nagarro share capital secured in the takeover offer

Sandeep Kalra · Executive Director and Chief Executive Officer · p. 6
“We have secured approximately 94.04% of Nagarro share capital excluding treasury shares at the expiry of the additional acceptance period, significantly exceeding the minimum acceptance threshold of 50% + 1 share that we had set.”

Squeeze-out of Nagarro minority holders planned after closing

Sandeep Kalra · Executive Director and Chief Executive Officer · p. 6
“Having secured more than 90% of Nagarro share capital and voting rights, we intend doing a squeeze out of the remaining minority shareholders of Nagarro upon closing.”

Combined group to have over $2.9 billion revenue run rate and 46,000+ staff

Sandeep Kalra · Executive Director and Chief Executive Officer · p. 6
“with over $2.9 billion in revenue run rate and 46,000 plus professionals across 40 countries.”

All merger control and FDI clearances received except Austria and Spain

Sandeep Kalra · Executive Director and Chief Executive Officer · p. 6
“From a merger control clearance perspective, we have received all merger control clearances and all FDI clearances other than Austria and Spain.”

Nagarro deal closure expected by Q4-CY26 or Q1-CY27

Sandeep Kalra · Executive Director and Chief Executive Officer · p. 7
“We expect the deal closure by Q4-CY26 or Q1-CY27.”

One-offs

Nagarro one-time expenses cut reported PAT by about 3.1% in the quarter

Sandeep Kalra · Executive Director and Chief Executive Officer · p. 4
“I would like to point out that the reported PAT includes exceptional one-time expenses as part of Nagarro acquisition, resulting in approximately 3.1% impact for the quarter.”

Nagarro transaction costs of Rs 1,853.4 million in the quarter

Vinit Teredesai · Executive Director and Chief Financial Officer · p. 9
“We incurred transaction costs worth Rs. 1,853.4 million towards the Nagarro acquisition in this quarter.”

USD 50 million deal cost covers banking fees, bridge loan costs, legal and filings

Vinit Teredesai · Executive Director and Chief Financial Officer · Q&A · p. 22
“Yeah, so this 50 million is basically a combination of multiple. It is a combination of the investment banking fees, the bridge loan commitment costs, there are legal lawyer costs, we are doing application of regulatory filings in various geographies, various travel involved with that.”

USD 25 to 30 million more deal costs over next 3 to 4 quarters

Vinit Teredesai · Executive Director and Chief Financial Officer · Q&A · p. 23
“million is what basically is incurred in Q2. And as I said, 25 to 30 million will be incurred over the next 3 to 4 quarters.”

Risks

Forward contracts of USD 500 million at average 95.6 per dollar

Vinit Teredesai · Executive Director and Chief Financial Officer · p. 9
“Forward contracts outstanding as of 30th September, 2026 were USD 500 million at an average rate of 95.6 per dollar.”

Some deals slipped; slower decision making in recent weeks

Sandeep Kalra · Executive Director and Chief Executive Officer · Q&A · p. 19
“We had a few deals that slipped over into this quarter, no excuses, we could have done better. But yes, the macro does impact us. The slowdown of decision making in the last few weeks was pretty apparent.”

Some deals affected by Middle East dynamics

Sandeep Kalra · Executive Director and Chief Executive Officer · Q&A · p. 19
“And some of these get impacted when the Middle East dynamics kind of go up or down.”

Other

Q2 FY27 revenue USD 487.6 million, up 7.8% QoQ and 20% YoY

Sandeep Kalra · Executive Director and Chief Executive Officer · p. 4
“We achieved a healthy revenue growth of 7.8% quarter-on-quarter and 20% year-on-year delivering USD 487.6 million in Q2 FY27.”

Board may seek approval to exclude deal costs from 12% ESOP vesting tests

Sandeep Kalra · Executive Director and Chief Executive Officer · p. 7
“Also, as you may be aware, our ESOP vesting criteria for our team members is conditional on achieving a 12% revenue growth and a 12% EPS growth. In line with this, the Board may seek shareholders' approval to treat these one-time transaction related expenses as an exception when assessing the ESOP vesting conditions.”

Headcount 29,598, up 958 from the previous quarter

Vinit Teredesai · Executive Director and Chief Financial Officer · p. 8
“our total headcount stood at 29,598, an increase of 958 from previous the quarter.”

Utilisation 85.8%, down 70 bps, due to hiring for large deal ramp-ups

Vinit Teredesai · Executive Director and Chief Financial Officer · p. 8
“Utilization stood at 85.8%, down 70 basis sequentially, primarily reflecting proactive hiring to support the ramp-up of large deals.”

Trailing 12-month attrition 11.9% vs 12.3% last quarter

Vinit Teredesai · Executive Director and Chief Financial Officer · p. 8
“Trailing 12-months attrition stood at 11.9% compared to 12.3% in the previous quarter.”

Sources

Management's own statements, quoted from its NSE filings. This page was read by AI and can contain mistakes: check the source pages before relying on any figure. No forecast or opinion of ours. Not investment advice.

Search

Search funds, ETFs, stocks, pages and tools